David Katzenstein

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Scott M. Hammer, David Katzenstein, Michael D. Hughes et al. · New England Journal of Medicine · 1996 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Treatment for Adult HIV Infection

Scott M. Hammer, Michael S. Saag, Mauro Schechter et al. · JAMA · 2006 · 1K citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

Treatment for Adult HIV Infection

Patrick Yéni, Scott M. Hammer, Martin Hirsch et al. · JAMA · 2004 · 737 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

David Katzenstein, Scott M. Hammer, Michael D. Hughes et al. · New England Journal of Medicine · 1996 · 485 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

Victor DeGruttola, Lynn P. Dix, Richard T. D’Aquila et al. · Antiviral Therapy · 2000 · 330 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +13